TrialPsychopharmacology2010

Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients.

Lucia Sara Volonteri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.